Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk - Top-Institutions - MDSpire

Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk

  • By

  • Jiawang Huang

  • Xiuli Xu

  • Yucheng Jin

  • Liping Qiao

  • Heng Yu

  • Wenbo Gao

  • Caie Li

  • June 4, 2026

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Brigham Health System
    Massachusetts General Brigham Health System

    Boston, MA

    Key Differentiators

    • Cardiology
    • Oncology

  • #2

    Stephenson Cancer Center
    Stephenson Cancer Center

    Oklahoma City, OK

    Key Differentiators

    • Oncology
    • Cardiology

  • #3

    Taipei Medical University Hospital
    Taipei Medical University Hospital

    Taipei, Taiwan

    Key Differentiators

    • Cardiology

  • #4

    Spanish National Center for Cardiovascular Research
    Spanish National Center for Cardiovascular Research

    Madrid, Spain

    Key Differentiators

    • Cardiology

  • #5

    CIBER-CV (Center for Biomedical Network Research Cardiovascular)
    CIBER-CV (Center for Biomedical Network Research Cardiovascular)

    Madrid, Spain

    Key Differentiators

    • Cardiology

Original Source(s)

Mechanisms and biomarkers of immune checkpoint inhibitor-associated myocarditis: from T cell imbalance to multicellular crosstalk

  • by Jiawang Huang, Xiuli Xu, Yucheng Jin, Liping Qiao, Heng Yu, Wenbo Gao, Caie Li

  • June 4, 2026

Related Content

Understanding cardiac toxicity and immune responses to thoracic radiation therapy in non-small cell lung cancer – implications for future research

Manufacturability and the Winners in Advanced Therapies

Are developers still underestimating the engineering sophistication required to scale advanced therapies in the real world? Alan Boyd discusses.

Belzutifan-induced tumor regression in sporadic hemangioblastoma: a case report and literature review